Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)

NCT07779746 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT07779746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07779746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)
Lead sponsor
Unity Health Toronto
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
November 30, 2032
Enrollment
848 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial flutter, dialysis patients, end stage kidney disease (esrd)